Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 — Louisville, Kentucky

Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 is a clinical research site located in Louisville, Kentucky, United States 40291.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Disease.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2?

Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 conducted?

Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 has 1 clinical trials on record. Their work covers Meningococcal Disease.

Is Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 accredited by Crixeo Health?

Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.